June 2022
Volume 63, Issue 7
Open Access
ARVO Annual Meeting Abstract  |   June 2022
Prediction of Glaucoma Development from Glaucoma Suspect with OCT Structural Measurements using Artificial Intelligence
Author Affiliations & Notes
  • Sasan Moghimi
    Viterbi Family Department of Ophthalmology, Hamilton Glaucoma Center, Shiley Eye Institute, La Jolla, California, United States
  • Vahid Mohammadzadeh
    Viterbi Family Department of Ophthalmology, Hamilton Glaucoma Center, Shiley Eye Institute, La Jolla, California, United States
  • Takashi Nishida
    Viterbi Family Department of Ophthalmology, Hamilton Glaucoma Center, Shiley Eye Institute, La Jolla, California, United States
  • Evan Walker
    Viterbi Family Department of Ophthalmology, Hamilton Glaucoma Center, Shiley Eye Institute, La Jolla, California, United States
  • Golnoush Mamoudinezhad
    Viterbi Family Department of Ophthalmology, Hamilton Glaucoma Center, Shiley Eye Institute, La Jolla, California, United States
  • Jo-Hsuan Wu
    Viterbi Family Department of Ophthalmology, Hamilton Glaucoma Center, Shiley Eye Institute, La Jolla, California, United States
  • Jeffrey M Liebmann
    Department of Ophthalmology, Edward S. Harkness Eye Institute, Columbia University Medical Center, 2 Bernard and Shirlee Brown Glaucoma Research Laboratory, New York, New York, United States
  • Christopher A Girkin
    Bernard School of Medicine, University of Alabama-Birmingham, Birmingham, Alabama, United States
  • Linda M Zangwill
    Viterbi Family Department of Ophthalmology, Hamilton Glaucoma Center, Shiley Eye Institute, La Jolla, California, United States
  • Tara Javidi
    University of California San Diego Jacobs School of Engineering, La Jolla, California, United States
  • Robert N Weinreb
    Viterbi Family Department of Ophthalmology, Hamilton Glaucoma Center, Shiley Eye Institute, La Jolla, California, United States
  • Footnotes
    Commercial Relationships   Sasan Moghimi None; Vahid Mohammadzadeh None; Takashi Nishida None; Evan Walker None; Golnoush Mamoudinezhad None; Jo-Hsuan Wu None; Jeffrey Liebmann Alcon, Allergan, Bausch & Lomb, Carl Zeiss Meditec, Heidelberg Engineering, Reichert, Valeant Pharmaceuticals, Code C (Consultant/Contractor), Bausch & Lomb, Carl Zeiss Meditec, Heidelberg Engineering, National Eye Institute, Novartis, Optovue, Reichert Technologies, Research to Prevent Blindness, Code F (Financial Support); Christopher Girkin National Eye Institute, EyeSight Foundation of Alabama, Research to Prevent Blindness, Heidelberg Engineering, GmbH, Code F (Financial Support); Linda Zangwill Abbvie Inc. Digitial Diagnostics, Code C (Consultant/Contractor), National Eye Institute, Carl Zeiss Meditec Inc., Heidelberg Engineering GmbH, Optovue Inc., Topcon Medical Systems Inc., Code F (Financial Support), Zeiss Meditec, Code P (Patent); Tara Javidi None; Robert Weinreb Abbvie, Aerie Pharmaceuticals, Allergan, Equinox, Eyenovia, Nicox, Topcon, Code C (Consultant/Contractor), Heidelberg Engineering, Carl Zeiss Meditec, Konan Medical, Optovue, Centervue, Bausch&Lomb, Topcon, Code F (Financial Support), Toromedes, Carl Zeiss Meditec, Code P (Patent)
  • Footnotes
    Support  UC Tobacco-Related Disease Research Program T31IP1511, R01EY029058, R01EY11008, R01EY19869, R01EY027510, R01EY026574, P30EY022589, EY018926; Unrestricted grant from Research to Prevent Blindness (New York, NY)
Investigative Ophthalmology & Visual Science June 2022, Vol.63, 2028 – A0469. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Sasan Moghimi, Vahid Mohammadzadeh, Takashi Nishida, Evan Walker, Golnoush Mamoudinezhad, Jo-Hsuan Wu, Jeffrey M Liebmann, Christopher A Girkin, Linda M Zangwill, Tara Javidi, Robert N Weinreb; Prediction of Glaucoma Development from Glaucoma Suspect with OCT Structural Measurements using Artificial Intelligence. Invest. Ophthalmol. Vis. Sci. 2022;63(7):2028 – A0469.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : To investigate the ability of macular and circumpapillary retinal nerve fiber (cpRNFL) change rates and clinical/demographic factors to predict development of glaucoma from glaucoma suspects (GS) through elastic net regression (ENR) and machine learning (ML) models.

Methods : 162 eyes of 146 patients with GS were included. The eyes were required to have characteristic glaucomatous optic nerve changes without visual field (VF) defects. Development of glaucoma was defined as having VF glaucoma hemifield test outside normal limit and pattern standard deviation 5% in 3 consecutive exams. Global and sectoral rates of change of macular ganglion cell/inner plexiform layer (GCIPL) and cpRNFL OCT were calculated with linear mixed-effect models. The ENR and ML models, gradient boost model (GBM), support vector machine (SVM) and Naïve Bayes (NB) were fit for structural rates of change and clinical/demographic parameters in order to predict the development of glaucoma in GS. Parameter tuning with Grid Search Method and 5-fold cross validation were applied for each ML model.

Results : 47 eyes developed glaucoma based on the study criteria. The average follow-up time was 2.3 and 2.1 years for glaucoma and GS eyes, respectively. The rates of average GCIPL were significantly faster in the eyes that converted to glaucoma (= –0.10, P<0.001) and the average cpRNFL rates was not significant (= –0.15, P=0.152). Predictive factors that were selected by ENR were average, minimum, superior and temporal superior GCIPL change rates and average intraocular pressure (IOP) during follow-up (AUC (95% confidence interval (CI)=0.71 (0.62, 0.80)). Parameters with highest relative importance from GBM were average GCIPL rates, average IOP during follow-up, age, axial length temporal superior and temporal inferior GCIPL and temporal cpRNFL change rates (Figure 1). The AUC (95% CI) for prediction of glaucoma development was 0.91 (0.86, 0.97), 0.87 (0.81, 0.92) and 0.82 (0.75, 0.89) for GBM, SVM and NB, respectively (Figure 2).

Conclusions : Development of glaucoma in glaucoma suspect eyes can be predicted from longitudinal macular and cpRNFL OCT data and average IOP during follow-up with clinically relevant accuracy. The proposed models may assist clinicians to predict better the development of glaucoma.

This abstract was presented at the 2022 ARVO Annual Meeting, held in Denver, CO, May 1-4, 2022, and virtually.

 

 

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×